News and Announcements
CEO Dr James Garner speaks about GDC-0084 data with Proactive Investors
- Published November 25, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Our CEO, Dr James Garner discussed the significance of the interim efficacy data from Kazia’s phase II trial of GDC-0084 in glioblastoma in an interview with Proactive Investors.
In the interview, Dr Garner talks about:
- How the median progression-free survival rate of 8.3 months strongly suggests that GDC-0084 is delaying the progression of glioblastoma in the patients treated
- How the data signals that GDC-0084 may be extending life expectancy for the patients treated
- How the data compares to the existing treatment option for glioblastoma, temozolomide
- The next steps for the phase II study and Kazia more generally
Watch the video interview here
About KaziaTherapeutics Limited
Kazia Therapeutics Limited (ASX: KZA, NASDAQ: KZIA) is an innovative oncology-focused biotechnology company, based in Sydney, Australia. Our pipeline includes two clinical-stage drug development candidates, and we are working to develop therapies across a range of oncology indications.
Company Updates
Bridging the Gap: Why Australian Capital is Crucial for India’s Trillion-Dollar Growth Story
Australia’s substantial savings pool is meeting India’s explosive growth. Learn how Creek Partners is building the crucial bridge for investors seeking to tap into India’s projected $7 trillion economy and its vibrant venture capital ecosystem.
Beyond the Hype: Strategic Digital Asset Investing for a New Financial Era
The financial world is undergoing a profound transformation driven by Digital Assets. Learn why hundreds of billions are pouring into new digital infrastructure, with stablecoins now outperforming Mastercard/Visa in transaction volume. This article guides investors beyond the hype to strategic digital asset investing, exploring yield, DePIN, DeFi, and AI+Blockchain for the new financial era. Discover more at Venture & Capital SYDNEY 2025.
Cryptos New Frontier: Institutionalisation, Real-World Assets, and the End of Wild West Investing
The cryptocurrency landscape, once characterised by rapid cycles and speculative frenzy, is undergoing a profound transformation. As global institutions and high-net-worth individuals increasingly look to allocate capital to digital assets, the focus is shifting towards maturity, regulatory clarity, and the integration of blockchain technology with traditional finance. A recent at the Emergence Singapore 2025 panel […]
Backed By Leading Investment Groups and Family Offices
